Management ChangeMay 18, 2026, 04:37 PM
Medtronic Announces Executive VP Wall's Departure; Thompson Named Neuroscience President
AI Summary
Medtronic plc announced that Brett Wall will depart from his role as Executive Vice President and President, Neuroscience Portfolio. Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will succeed him, effective June 1, 2026. Mr. Wall will remain with the company until September 1, 2026, to facilitate a smooth transition and will receive severance benefits consistent with Medtronic's executive severance practices.
Key Highlights
- Brett Wall to depart as Executive Vice President and President, Neuroscience Portfolio.
- Dr. Kweli Thompson appointed Executive Vice President and President, Neuroscience Portfolio.
- Dr. Thompson's new role is effective June 1, 2026.
- Mr. Wall will remain an employee until September 1, 2026, to assist with the transition.
- Mr. Wall will receive severance payments and benefits consistent with company practices.
Price Impact
More from MDT